Kosir M A, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish L K, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan N P, Kozol R A
VA Medical Center, Detroit, Michigan 48201, USA.
J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233.
During surgery, the balance between thrombosis and fibrinolysis is altered. Methods reported to increase fibrinolysis, such as compression devices, may reduce venous thrombosis. However, there are no prospective studies comparing methods and the effect on fibrinolysis.
In a prospective study, general surgical patients were randomized to either sequential compression devices (Group 1) or subcutaneous heparin (Group 2), and fibrinolysis factors were measured in order to determine the effect on the fibrinolysis system. Blood samples were drawn at a similar time of the day with the tourniquet off. Specifically, t-PA antigen, plasminogen activator inhibitor-1 (PAI-1), and D-dimer were measured preoperatively (preop) and on Postoperative Days (POD) 1 and 7 by the ELISA method. Fibrinolysis factors were reported as the mean +/- SD and as percentage change from preoperative values. Noninvasive vascular studies were performed preop, and on POD 1, 7, and 30, by an examination of the infrainguinal venous system and external iliac veins in bilateral lower extremities. Nonambulatory patients were excluded from the study and DVT prophylaxis methods were initiated at surgery and used through POD 2.
For the 136 patients in the study, there were no differences in clinical characteristics such as age, surgical time (all > 60 min), anesthesia type (general or spinal), type of surgical procedure, or other risk factors for DVT. Two DVTs occurred at POD 1 and 30 (both Group 2), and one pulmonary embolism in each group (POD 7 for Group 1; POD 1 for Group 2). For subjects without thrombosis, D-dimer changes were parallel for both groups, increasing through POD 7. Similarly, t-PA antigen levels rose from baseline on POD 1 in both groups, with a return toward baseline by POD 7. The PAI-1 levels increased on POD 1 in both groups, but severalfold more in Group 1 (compression devices). The elevation in PAI-1 decreased by 50% in Group 1 by POD 7, while values returned to normal in Group 2. These changes were not significant using the Mann-Whitney test. Only three patients had thrombotic episodes so that data on changes in fibrinolysis factors are difficult to compare with the larger group.
This is the first report of a prospective, randomized comparison of fibrinolysis factors using sequential compression devices in comparison to low dose unfractionated heparin in general surgical patients, and comparing postoperative values to preop. Both groups showed an enhanced fibrinolysis by elevation in t-PA antigen and D-dimer on POD 1, as expected when fibrinolysis occurs. While PAI-1 and t-PA work in parallel, the marked elevation of PAI-1 on POD 1 (although only slightly above reference values) and continuing into POD 7 for subjects using compression devices requires further inquiry. The elevation of PAI-1 in the face of elevated t-PA and D-dimer has been reported, but the comparison between patients using sequential compression devices and mini-dose heparin has not been reported. The reason for the elevation requires additional study into other influences on the synthesis, secretion, and/or function of PAI-1 that do not affect t-PA.
手术过程中,血栓形成与纤溶之间的平衡会发生改变。据报道,一些可增强纤溶的方法,如压迫装置,可能会减少静脉血栓形成。然而,尚无前瞻性研究比较不同方法及其对纤溶的影响。
在一项前瞻性研究中,将普通外科患者随机分为两组,一组使用序贯压迫装置(第1组),另一组皮下注射肝素(第2组),并检测纤溶因子以确定对纤溶系统的影响。在一天中相同时间且松开止血带的情况下采集血样。具体而言,采用酶联免疫吸附测定法在术前(preop)、术后第1天(POD 1)和第7天(POD 7)检测组织型纤溶酶原激活物(t-PA)抗原、纤溶酶原激活物抑制剂-1(PAI-1)和D-二聚体。纤溶因子以平均值±标准差以及相对于术前值的百分比变化形式报告。术前以及POD 1、7和30时,通过检查双侧下肢腹股沟下静脉系统和髂外静脉进行非侵入性血管研究。不活动的患者被排除在研究之外,在手术时开始采用深静脉血栓形成(DVT)预防措施,并持续至POD 2。
本研究中的136例患者在年龄、手术时间(均>60分钟)、麻醉类型(全身麻醉或脊髓麻醉)、手术方式或其他DVT危险因素等临床特征方面无差异。在POD 1和30时发生了2例DVT(均在第2组),每组各有1例肺栓塞(第1组为POD 7;第2组为POD 1)。对于无血栓形成的受试者,两组的D-二聚体变化趋势平行,至POD 7时均升高。同样,两组的t-PA抗原水平在POD 1时均从基线上升,至POD 7时恢复至基线水平。两组的PAI-1水平在POD 1时均升高,但第1组(压迫装置组)升高幅度达数倍。第1组至POD 7时PAI-1升高幅度下降了50%,而第2组的值恢复正常。使用曼-惠特尼检验时,这些变化无统计学意义。仅有3例患者发生血栓事件,因此纤溶因子变化的数据难以与更大的组进行比较。
这是首篇关于普通外科患者中使用序贯压迫装置与低剂量普通肝素进行纤溶因子前瞻性、随机对照比较,并将术后值与术前值进行比较的报告。两组在POD 1时均出现t-PA抗原和D-二聚体升高,提示纤溶增强,这与预期一致。虽然PAI-1和t-PA协同作用,但使用压迫装置的受试者在POD 1时PAI-1显著升高(尽管仅略高于参考值)且持续至POD 7,这一现象需要进一步研究。虽然已有报道在t-PA和D-二聚体升高的情况下PAI-1也升高,但使用序贯压迫装置的患者与小剂量肝素使用者之间的比较尚未见报道。PAI-1升高的原因需要对不影响t-PA的PAI-1合成、分泌和/或功能的其他影响因素进行更多研究。